5-87390806-T-A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_002890.3(RASA1):c.3067T>A(p.Leu1023Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L1023L) has been classified as Likely benign.
Frequency
Consequence
NM_002890.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.00000399  AC: 1AN: 250776 AF XY:  0.00   show subpopulations 
GnomAD4 exome Cov.: 30 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Capillary malformation-arteriovenous malformation syndrome    Uncertain:1 
This sequence change replaces leucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1023 of the RASA1 protein (p.Leu1023Met). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with RASA1-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at